Medicus Pharma Ltd. MDCX

Annual Quarterly

No annual revenue total was found in MEDICUS PHARMA LTD.'s SEC filings.

Medicus Pharma Ltd. (MDCX) files with the SEC under industry code 2834, Pharmaceutical Preparations. As of Jun 30, 2026 it held $15.2 million in cash and investments and $137,330 in total debt.

Revenue
—
Net income (TTM)
$-56.66M
Operating cash flow (TTM)
$-29.32M
Free cash flow
—
EPS (TTM)
$-1.67
Dividend per share
None
Shares outstanding
41.82M
+6.2% vs prior year
Net cash
$15.04M
as of Jun 30, 2026
Operating margin
—

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MDCX (Nasdaq), MDCXW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Ontario, Canada
Headquarters
W. Conshohocken, PA
SEC filer status
, Emerging growth company
SEC CIK
1997296

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
Operating income
-$34.4M
-$11.2M
Net income
-$47.3M
-$11.2M
Diluted EPS
-$2.74
-$1.16
Operating cash flow
-$22.8M
-$10.2M
Total assets
$10.1M
$5.6M
Total liabilities
$10.0M
$2.5M
Stockholders' equity
-$67,554
—
Cash and investments
$8.7M
$4.2M
Total debt
$205,595
$322,268

Recent SEC filings

Form Description Filed Period
8-K Current report
Regulation FD disclosure
 Nov 4, 2026 Nov 4, 2026
8-K Current report
Listing notice, Other events
 Oct 23, 2026 Oct 20, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
 Oct 16, 2026 Oct 12, 2026
8-K Current report
Other events
 Oct 7, 2026 Oct 7, 2026
8-K Current report
Agreement ended
 Sep 14, 2026 Sep 11, 2026
8-K Current report
Unregistered share sale
 Sep 11, 2026 Sep 4, 2026

All 343 Medicus Pharma Ltd. SEC filings

Source: SEC EDGAR filings. This is company-reported data, not investment advice.